Browsing byAuthorPathak, S

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)
2022-10-13A Re-Evaluation of Past to Present-Day Use of the Blissful Neuronal Nutraceutical “Cannabis”Dhanasekaran, M; M. Nadar, R; McDonald, K; Deruiter, J; Pathak, S; Ramesh, S; Vijayarani, R; Gopal, K; Babu Ramapuram, J; Dua, K; Moore, T; Ren, J; Dhanasekaran, M
1997-05-01Low-level c-myc amplification in human colonic carcinoma cell lines and tumors: A frequent, p53-independent mutation associated with improved outcome in a randomized multi-institutional trialAugenlicht, LH; Wadler, S; Corner, G; Richards, C; Ryan, L; Multani, AS; Pathak, S; Benson, A; Haller, D; Heerdt, BG
2020-01-01Oxidative stress in neurology and in neurodegenerative processesGupta, G; Pathak, S; Rawat, S; Mishra, A; Singh, Y; Mehta, M; Satija, S; Khurana, N; De Jesus Andreoli Pinto, T; Shukla, S; Pabreja, K; Chellappan, DK
2017-05-01Pharmacological evaluation of aqueous extract of syzigium cumini for its antihyperglycemic and antidyslipidemic properties in diabetic rats fed a high cholesterol diet—Role of PPARγ and PPARαSharma, S; Pathak, S; Gupta, G; Sharma, SK; Singh, L; Sharma, RK; Mishra, A; Dua, K
2022-01-03PREVENTIVE ROLE OF SAPINDUS SPECIES IN DIFFERENT NEUROLOGICAL AND METABOLIC DISORDERSRawat, S; Gupta, G; Mishra, A; Pathak, S; Thangavelu, L; Singh, SK; Jha, NK; Kumar, D; Negi, P; Kumar, AP; Chellappan, DK; Dua, K
2021-01Recent update on barbiturate in relation to brain disorder.Pathak, S; Gupta, G; Thangavelu, L; Singh, SK; Dua, K; Chellappan, DK; Gilhotra, RM
2020-08The Impact of COVID-19 Pandemic Infection in Patients Admitted to the Hospital for Reasons Other Than COVID-19 Infection.Rawat, S; Singh Dhramshaktu, I; Pathak, S; Kumar Singh, S; Singh, H; Mishra, A; Gilhotra, R; Kumar Chellappan, D; Dua, K; Gupta, G